Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

BACKGROUND: The increased detection of small-sized peripheral non-small-cell lung cancer (NSCLC) has renewed interest in sublobar resection in lieu of lobectomy. Overall survival was similar with the two procedures.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 METHODS: We conducted a multicenter, noninferiority, phase 3 trial in which patients with NSCLC clinically staged as T1aN0 (tumor size, ≤2 cm) were randomly assigned to undergo sublobar resection or lobar resection after intraoperative confirmation of node-negative disease.
• 2 The primary end point was disease-free survival, defined as the time between randomization and disease recurrence or death from any cause.
• 3 Secondary end points were overall survival, locoregional and systemic recurrence, and pulmonary functions.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: